Almirall Logo
  • About Us
  • Therapeutic Focus
  • Prescription Medicines
  • Social Responsibility
    • Transparency
  • Helpful Resources

    • Select your Almirall

    • Worldwide
    • France
    • Germany
    • Italy
    • Netherlands
    • Poland
    • Spain
    • Spain (català)
    • Austria
    • Switzerland
    • United Kingdom
    • Czechia
    • Slovakia
    • Nordics
  • Careers
  • Investors

View all results

Back to newsroom

Almirall U.S. Supports The Skin Cancer Foundation’s Mobile Skin Cancer Screening Program

08 November 2021
  • The Foundation’s Destination Healthy Skin RV visits communities around the U.S. to raise skin cancer awareness

Resources

  • Download news   PDF (326KB)

Back to newsroom

05 May 2025

Almirall and Biofrontera Launch the ‘Hats On’ Challenge to Raise Awareness and Support for Actinic Keratosis

24 February 2025

Almirall surpassed guidance for 2024 - entering an era of sustained growth and further advancing its Medical Dermatology pipeline.

21 March 2025

Almirall's 16th Skin Academy brings together leading experts to advance skin science and treatment options in Medical Dermatology

View all press

Logo footer
  • Contact Us
  • News
  • Terms of Use
  • Privacy Policy
  • Consumer Health Privacy Notice
  • Cookies Policy

Contents © 2005-2024 Almirall, LLC, Malvern, PA 19355. All Rights Reserved. 01/2024 US-NOP-2400001

Facebook Instagram Linkedin Twitter

By clicking on the link below, you acknowledge that you are leaving the Almirall, LLC - U.S. website.

Would you like to continue?

No

Yes

By clicking on the link below, you acknowledge that you are leaving the Almirall, LLC - U.S. website.

Would you like to continue?

No

Yes

The content you are about to see is restricted to media professional use

Please let us know if you are a professional to continue.

Cancel

I'm a media professional

Your browser is not compatible with our website.

The version of Internet Explorer you are using is outdated. To have a complete user experience in almirall.com, we recommend you to update your browser or enter from the latest versions of Edge, Chrome, Safari, Opera or Firefox.

OK